Back to Search Start Over

Chronic Cough and Gastroesophageal Reflux in Children

Authors :
Anne B. Chang
John J. Oppenheimer
Peter J. Kahrilas
Ahmad Kantar
Bruce K. Rubin
Miles Weinberger
Richard S. Irwin
Todd M. Adams
Kenneth W. Altman
Elie Azoulay
Alan F. Barker
Donald C. Bolser
Surinder S. Birring
Sidney S. Braman
Christopher Brightling
Priscilla Callahan-Lyon
Terrie Cowley
Paul Davenport
Ali A. El Solh
Patricio Escalante
Stephen K. Field
Dina Fisher
Cynthia T. French
Cameron Grant
Peter Gibson
Susan M. Harding
Philip Gold
Anthony Harnden
Adam T. Hill
Joanne Kavanagh
Kefang Lai
Kaiser Lim
J. Mark Madison
Mark A. Malesker
Stuart Mazzone
Lorcan McGarvey
Joshua P. Metlay
Alex Molasoitis
M. Hassan Murad
Mangala Narasimhan
Peter Newcombe
John Oppenheimer
Mark Rosen
Bruce Rubin
Richard J. Russell
Jay H. Ryu
Sonal Singh
Jaclyn Smith
Maeve P. Smith
Susan M. Tarlo
Julie Turmel
Anne E. Vertigan
Source :
Chest. 156:131-140
Publication Year :
2019
Publisher :
Elsevier BV, 2019.

Abstract

Background Whether gastroesophageal reflux (GER) or GER disease (GERD) causes chronic cough in children is controversial. Using the Population, Intervention, Comparison, Outcome (PICO) format, we undertook four systematic reviews. For children with chronic cough (> 4-weeks duration) and without underlying lung disease: (1) who do not have gastrointestinal GER symptoms, should empirical treatment for GERD be used? (2) with gastrointestinal GER symptoms, does treatment for GERD resolve the cough? (3) with or without gastrointestinal GER symptoms, what GER-based therapies should be used and for how long? (4) if GERD is suspected as the cause, what investigations and diagnostic criteria best determine GERD as the cause of the cough? Methods We used the CHEST Expert Cough Panel's protocol and American College of Chest Physicians (CHEST) methodological guidelines and GRADE (Grading of Recommendations Assessment, Development and Evaluation) framework. Delphi methodology was used to obtain consensus. Results Few randomized controlled trials addressed the first two questions and none addressed the other two. The single meta-analysis (two randomized controlled trials) showed no significant difference between the groups (any intervention for GERD vs placebo for cough resolution; OR, 1.14; 95% CI, 0.45-2.93; P = .78). Proton pump inhibitors (vs placebo) caused increased serious adverse events. Qualitative data from existing CHEST cough systematic reviews were consistent with two international GERD guidelines. Conclusions The panelists endorsed that: (1) treatment(s) for GERD should not be used when there are no clinical features of GERD; and (2) pediatric GERD guidelines should be used to guide treatment and investigations.

Details

ISSN :
00123692
Volume :
156
Database :
OpenAIRE
Journal :
Chest
Accession number :
edsair.doi...........fe0ea35139c4e75c9ced9e8d861d9359
Full Text :
https://doi.org/10.1016/j.chest.2019.03.035